Who
Carlos E. Santos
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Legend Biotech.
In numbers
- Trades disclosed
- 4
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $99K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 21 Sep 2026
- Last trade
- 21 Sep 2026
- Last filed
- 23 Sep 2026
Companies traded
Activity over time
1 Sep – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Sep 2026filed 23 Sep 2026 | LEGN Legend BiotechBiotechnology | SEC FORM 4 Code A | —19,676 at $0.00 | filing |
| 21 Sep 2026filed 23 Sep 2026 | LEGN Legend BiotechBiotechnology | SEC FORM 4 Sold | $50K5,430 at $9.14 | filing |
| 21 Sep 2026filed 23 Sep 2026 | LEGN Legend BiotechBiotechnology | SEC FORM 4 Code A | —19,676 at $0.00 | filing |
| 21 Sep 2026filed 23 Sep 2026 | LEGN Legend BiotechBiotechnology | SEC FORM 4 Sold | $50K5,430 at $9.14 | filing |
News
Contrasting Legend Biotech (NASDAQ:LEGN) & Connect Biopharma (NASDAQ:CNTB)LEGN · tickerreport.com · 13 Oct 2026
0 headlines in the last 90 days name Carlos E. Santos; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.